Impact of the national pneumococcal vaccination program on invasive pneumococcal disease in South Korea
Nakamura, T. et al. The global landscape of pediatric bacterial meningitis data reported to the World Health Organization-coordinated Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2014-2019. J. Infect. Say. 224S161–S173 (2021).
O’Brien, KL et al. Burden of disease caused by Streptococcus pneumoniae in children under 5: global estimates. Lancet (London, England). 374893–902 (2009).
Ben-Shimol, S., Regev-Yochay, G., Givon-Lavi, N., Van Der Beek, BA, Brosh-Nissimov, T., Peretz, A., et al. Dynamics of invasive pneumococcal disease in Israel in children and adults in the era of PCV13: a nationwide prospective surveillance. Clin. Infect. Say. (2021).
Chapman, R. et al. Ten-year public health impact of 13-valent pneumococcal conjugate vaccination in infants: a modeling analysis. Vaccine. 387138–7145 (2020).
Fitzwater, SP, Chandran, A., Santosham, M. & Johnson, HL The global impact of the seven-valent pneumococcal conjugate vaccine. Pediatrician Infect. Say. J 31501-508 (2012).
Feikin, Dominican Republic et al. Serotype-specific changes in invasive pneumococcal disease after the introduction of the pneumococcal conjugate vaccine: a pooled analysis from multiple surveillance sites. PLoS Med. tene1001517 (2013).
Weinberger, DM, Malley, R. & Lipsitch, M. Serotype replacement in disease after pneumococcal vaccination. Lancet (London, England). 3781962-1973 (2011).
Choe, YJ, Choi, EH & Lee, HJ The changing epidemiology of childhood pneumococcal disease in Korea. Infect. Chimimer. 45145-158 (2013).
Lee, JH et al. Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): A retrospective multicenter study. J. Korean Med. Science. 26174-183 (2011).
Hey, JY et al. Incidence and case fatality rates of community-acquired pneumonia and pneumococcal disease in Korean adults: analysis based on catchment population. PLOS ONE 13e0194598 (2018).
Park, DC et al. Distribution of serotypes and antimicrobial resistance of invasive and non-invasive diseases Streptococcus pneumoniae isolates in Korea between 2014 and 2016. Ann. Laboratory. Med. 39537-544 (2019).
Sohn, S., Hong, K., and Chun, BC. Assessing the effectiveness of pneumococcal conjugate vaccine for children in Korea with high immunization coverage using a propensity score corresponding to a national population cohort. Int. J. Infect. Say. (IJID) 93146-150 (2020).
Choi, E.H. et al. Recommended vaccination schedule for children and adolescents: Korean Pediatric Society Infectious Diseases Committee, 2018. Korean J. Pediatr. 62252–256 (2019).
Heo, JY, Seo, YB, Choi, WS, Kim, EJ, Jeong, HW, Lee, J., et al. Efficacy of pneumococcal vaccination against hospitalized pneumococcal pneumonia in the elderly: a prospective, test-negative study. J. Infect. Say. (2021).
Yu, JH et al. Sustained immunization coverage during the 2019 coronavirus disease outbreak in the Republic of Korea. Vaccines. 20209 (2019).
Park, M. Infectious Disease Laws: Prevention and Control Measures. Epidemiol. Health 39e2017033 (2017).
Yo, HS et al. A new surveillance indicator identifying optimal timeliness and accuracy: application to Korea’s national notifiable disease surveillance system for 2001-2007. Epidemiol. Infect. 1412634-2643 (2013).
Choe, YJ, Yang, JJ, Park, SK, Choi, EH & Lee, HJ Comparative coverage estimation between national immunization program vaccines and non-NIP vaccines in Korea. J. Korean Med. Science. 281283-1288 (2013).
World Health Organization. Vaccine Preventable Disease Surveillance Standards. 2nd ed. License: CC BY-NC-SA 3.0 IGO. https://apps.who.int/iris/handle/10665/275754 (World Health Organization, 2018).
Lee, S., Lee, K., Kang, Y. & Bae, S. Prevalence of serotype and multidrug resistance to respiratory isolates of Streptococcus pneumoniae among 265 adults and 36 children in Korea, 2002–2005. Microb. Drug resistance. (Larchmont, NY). 16135-142 (2010).
Yun, KW, Cho, EY, Hong, KB, Choi, EH & Lee, HJ Streptococcus pneumoniae type determination by multiplex polymerase chain reaction. J. Korean Med. Science. 26971–978 (2011).
Palmu, AA et al. Similar impact and replacement disease after introduction of pneumococcal conjugate vaccine in hospitalized children with invasive pneumococcal disease in Europe and North America. Vaccine. 391551-1555 (2021).
Lu, CY et al. Successful control of Streptococcus pneumoniae 19A switch to a primary catch-up vaccination program in Taiwan. Clin. Infect. Say. 691581-1587 (2019).
Nakano, S. et al. National surveillance of pediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugate vaccine, 2015-2017. Vaccine. 381818–1824 (2020).
Shimbashi, R. et al. Efficacy of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in adults, Japan, 2013-2017. Emergency Infect. Say. 262378-2386 (2020).
Lo, SW et al. Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole genome sequencing study. Lancet infected. Say 19759–769 (2019).
Choi, E.H. et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emergency Infect. Say. 14275-281 (2008).
Sing, HL et al. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive disease caused by serotype 3 in children: a systematic review and meta-analysis of observational studies. Clin. Infect. Say. 682135-2143 (2019).
Goettler, D. et al. Increase in Streptococcus pneumoniae pleural effusion/parapneumonic empyema associated with serotype 3 after the introduction of PCV13 in Germany. Vaccine. 38570–577 (2020).
Ho, PL, Law, PY & Chiu, SS Increased incidence of invasive pneumococcal disease caused by serotype 3 in children eight years after introduction of pneumococcal conjugate vaccine in Hong Kong. Hmm. Vaccine. Immunother. 15455–458 (2019).
Choe, YJ, Choe, SA & Cho, SI Trends in Infectious Disease Mortality, South Korea, 1983-2015. Emergency Infect. Say. 24320–327 (2018).
Choe, YJ et al. Emergence of non-vaccine serotype antibiotic-resistant pneumococci in nasopharyngeal carriage in children after the use of extended-valence pneumococcal conjugate vaccines in Korea. Vaccine. 344771–4776 (2016).